side effects retatrutide Effects: What Patients Should Know Retatrutide side effects: What to

GLP-1 Receptor Agonist Market Demand, Opportunity, 2026-2034 REPORT DETAILS GLP-1 Receptor Agonist Market Overview The global GLP-1 receptor agonist market size was valued at USD 61.89 billion in 2025

Zeno, Courtney Lee, Cindy Crawford, Raheleh Khorsan, Avi R

Developed by Eli Lilly, retatrutide simultaneously targets GLP-1, GIP, and glucagon receptors a mechanism that sets it apart from currently approved medicines such as semaglutide and tirzepatide

Whenever starting a new medication, always consult with a reputable board-certified doctor

J Biol Chem 1992;267:9300-6

Reporting bias and media attention: As media coverage grew around Ozempic and mood, patients and doctors may have become more vigilant in reporting any psychological symptoms on these drugs